靶向子宫内膜异位症治疗对中枢敏化患者的影响:系统综述与荟萃分析
该系统综述与荟萃分析检索多个数据库,纳入5项研究共1271例患者,评估中枢敏化对子宫内膜异位症药物或手术治疗结局的影响。中枢敏化患者比例为28.3%至80.2%,其术后疼痛评分变化较小(RR 0.79,95%CI 0.73-0.86),持续性疼痛显著更高(RR 2.27,95%CI 1.40-3.68)。
要点
- 中枢敏化患者术后疼痛评分变化较小(RR 0.79,95%CI 0.73-0.86)。
- 中枢敏化患者持续性疼痛风险更高(RR 2.27,95%CI 1.40-3.68)。
- 基线灾难化思维较高与子宫内膜异位症治疗结局较差相关。
核心结论
- 基线灾难化思维较高与接受子宫内膜异位症治疗的女性结局较差相关,这在咨询和决策中值得考虑。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、Cochrane对照试验中心注册库、Cochrane系统综述数据库、Science Citation Index Expanded和Emerging Sources Citation Index,无语言或日期限制。
- 共鉴定1821篇摘要,审查259篇全文,最终5项研究符合纳入标准,共纳入1271例患者。
- 使用纽卡斯尔-渥太华量表评估质量和偏倚风险,采用随机效应荟萃分析(DerSimonian和Laird法)估计合并风险比(RR)和95%置信区间。
主要发现
- 中枢敏化患者比例为28.3%至80.2%。
- 中枢敏化患者子宫内膜异位症手术后疼痛评分变化较小(RR 0.79,95%CI 0.73-0.86)。
- 中枢敏化患者持续性疼痛显著更高(RR 2.27,95%CI 1.40-3.68)。
临床怎么用
- 作者认为,基线灾难化思维较高与子宫内膜异位症治疗结局较差相关,这在咨询和决策中值得考虑。
局限性
- 一项研究无法获取荟萃分析数据。
- 另一项研究因是唯一描述药物治疗的研究而被排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Central sensitization (CSS), a condition where the central nervous system amplifies pain signals, may impact response to treatment of chronic pain conditions. The objective of this study is to determine if CSS affects outcomes after medical or surgical treatment for women with endometriosis via a systematic review and meta-analysis. DATA SOURCES: A systematic literature search using MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Review, Science Citation Index Expanded, and Emerging Sources Citation Index was conducted without language or date restrictions. The search strategy utilized MeSH and EMTREE terms to capture concepts related to central sensitization, endometriosis, and associated symptoms like dysmenorrhea. Interventions in the reviewed studies included medical treatment or surgery. METHODS OF STUDY SELECTION: Studies reporting on endometriosis outcomes in women with and wihout CSS were included in the review. We excluded studies which primarily focused on non-endometriosis pelvic pain syndromes. A total of 1821 abstracts were identified, and 259 full texts were reviewed for eligibility. Five studies met inclusion criteria encompassing a total of 1271 patients. Data for meta-analysis was not available for one study and another study was excluded as it was the only one describing medical treatment. The Newcastle-Ottawa scale was used to assess quality and risk of bias. Results were sythesized using random effect meta-anlayses to estimate the pooled risk ratio (RR) and 95% confience using the DerSimmonian and Laird methods. TABULATION, INTEGRATION, AND RESULTS: The percentage of patients with CSS ranged from 28.3% to 80.2%. Patients with CSS have smaller changes in pain scores after endometriosis surgery (RR 0.79, confidence interval 0.73-0.86) and significantly higher persistent pain (RR 2.27, confidence interval 1.40-3.68). CONCLUSION: Higher baseline catastrophization is associated with worse outcomes in women undergoing treatment for endometriosis. This is important to consider during counseling and decision-making.
引用
- Gomez-Llerena A, Shekawat P, Pradeep A, et al. The Impact of Targeted Endometriosis Treatment On Patients With Central Sensitization: Systematic Review and Meta Analysis. J Minim Invasive Gynecol. 2025. PMID: 40721059. doi:10.1016/j.jmig.2025.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。